CD8A and neoplasm: In immunogenic tumors, SLR14 significantly increases the tumor infiltration of cytotoxic CD8+ T cells, NK cells, and CD11b+ myeloid cells while decreasing the immunosuppressive CD4+FoxP3+ T reg cells.